Adding to this hypothesis is a study showing that clusterin is up-regulated in the cerebrospinal fluid (CSF) of Alzheimer's disease individuals and that higher CSF clusterin was associated with an increase in entorhinal cortex atrophy (Desikan et al., 2014). This evidence concerns the gene CLU and early-onset autosomal dominant Alzheimer disease.